Jump to content

EudraLex

From Wikipedia, the free encyclopedia

EudraLex is the collection of rules and regulations governing medicinal products in the European Union.

Volumes

[edit]

EudraLex consists of 10 volumes:

  • Concerning Medicinal Products for Human use:
    • Volume 1 - Pharmaceutical Legislation.
    • Volume 2 - Notice to Applicants.
      • Volume 2A deals with procedures for marketing authorisation.
      • Volume 2B deals with the presentation and content of the application dossier.
      • Volume 2C deals with Guidelines.
    • Volume 3 - Guidelines.
  • Concerning Medicinal Products for human use in clinical trials (investigational medicinal products).
    • Volume 10 - Clinical trials.
  • Concerning Veterinary Medicinal Products:
    • Volume 5 - Pharmaceutical Legislation.
    • Volume 6 - Notice to Applicants.
    • Volume 7 - Guidelines.
    • Volume 8 - Maximum residue limits.
  • Concerning Medicinal Products for Human and Veterinary use:
  • Miscellaneous:
    • Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)

Directives

[edit]

See also

[edit]

References

[edit]
  • Eudralex,The Rules Governing Medicinal Products in the European Union, European Communities Commission. Directorate-General for Industry, Pharmaceuticals and Cosmetics.
    • Vol. 1: Pharmaceutical legislation: medicinal products for human use. ISBN 92-828-2032-7
    • Vol. 2: Notice to applicants: medicinal products for human use. ISBN 0-11-975780-X
    • Vol. 3: Guidelines: medicinal products for human use. ISBN 92-828-2436-5
    • Vol. 4: Good manufacturing practices: medicinal products for human and veterinary use. ISBN 92-828-2029-7
    • Vol. 5: Pharmaceutical legislation: veterinary medicinal products. ISBN 92-828-2037-8
    • Vol. 6: Notice to applicants: veterinary medical products. ISBN 0-11-985351-5
    • Vol. 7. Guidelines: Veterinary medicinal products. ISBN 0-11-985366-3
  • Markus Hartmann and Florence Hartmann-Vareilles, The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research?, PLoS Clin Trials. 2006 June; 1(2): e13
[edit]
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy